{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:05:30Z","timestamp":1758935130503},"reference-count":54,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.leukres.2011.06.022","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T12:24:21Z","timestamp":1311942261000},"page":"1449-1452","source":"Crossref","is-referenced-by-count":14,"title":["Disease progression mechanism in myelodysplastic syndromes: Insight into the role of the microenvironment"],"prefix":"10.1016","volume":"35","author":[{"given":"Mariko","family":"Ishibashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideto","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoyuki","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2011.06.022_bib0005","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1182\/asheducation-2008.1.43","article-title":"MDS: a stem cell disorder\u2014but what exactly is wrong with the primitive hematopoietic cells in this disease?","author":"Nimer","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.leukres.2011.06.022_bib0010","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJMra0902908","article-title":"Myelodysplastic syndromes","volume":"361","author":"Tefferi","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.leukres.2011.06.022_bib0015","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1182\/blood.V79.7.1823.1823","article-title":"Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes","volume":"79","author":"Kibbelaar","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.022_bib0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1182\/blood.V80.1.217.217","article-title":"Clonal analysis of myelodysplastic syndrome: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization","volume":"80","author":"Gerritsen","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.022_bib0025","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1182\/blood.V81.6.1580.1580","article-title":"Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion","volume":"81","author":"Anastasi","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.022_bib0030","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/sj.leu.2400638","article-title":"Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117","volume":"11","author":"Haase","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.06.022_bib0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2001-12-0188","article-title":"Involvement and functional impairment of the CD34(+)CD38(\u2212)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8","volume":"100","author":"Nilsson","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.022_bib0040","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2011.06.022_bib0045","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet","year":"1997","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2011.06.022_bib0050","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1182\/blood.V88.6.1944.bloodjournal8861944","article-title":"Fluorouracil selectively spares acute myeloid leukemia cells with long-term growth abilities in immunodeficient mice and in culture","volume":"88","author":"Terpstra","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.022_bib0055","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/sj.leu.2401903","article-title":"The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells","volume":"14","author":"Jordan","year":"2000","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.06.022_bib0060","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1182\/blood.V97.12.3882","article-title":"Hoechst 33342 efflux identifies a subpopulation of cytogenetically normal CD34(+)CD38(\u2212) progenitor cells from patients with acute myeloid leukemia","volume":"97","author":"Feuring-Buske","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.022_bib0065","doi-asserted-by":"crossref","first-page":"11008","DOI":"10.1073\/pnas.0704271104","article-title":"CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia","volume":"104","author":"Hosen","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2011.06.022_bib0070","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0145-2126(02)00221-7","article-title":"NOD\/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors","volume":"27","author":"Benito","year":"2003","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.06.022_bib0075","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1182\/blood-2003-09-3192","article-title":"Engraftment of NOD\/SCID-beta2 microglobulin null mice with multilineage neoplastic cells from patients with myelodysplastic syndrome","volume":"103","author":"Thanopoulou","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.022_bib0080","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1634\/stemcells.2004-0280","article-title":"Identification and hematopoietic potential of CD45\u2212 clonal cells with very immature phenotype (CD45\u2212CD34\u2212CD38\u2212Lin\u2212) in patients with myelodysplastic syndromes","volume":"23","author":"Ogata","year":"2005","journal-title":"Stem Cells"},{"key":"10.1016\/j.leukres.2011.06.022_bib0085","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/bies.20000","article-title":"Problems of somatic mutation and cancer","volume":"26","author":"Frank","year":"2004","journal-title":"Bioessays"},{"key":"10.1016\/j.leukres.2011.06.022_bib0090","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1002\/bies.20087","article-title":"The somatic mutation theory of cancer: growing problems with the paradigm?","volume":"26","author":"Soto","year":"2004","journal-title":"Bioessays"},{"key":"10.1016\/j.leukres.2011.06.022_bib0095","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/jcb.22497","article-title":"The evolutionary mechanism of cancer","volume":"109","author":"Heng","year":"2010","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.leukres.2011.06.022_bib0100","first-page":"3230","article-title":"A mutator phenotype in cancer","volume":"61","author":"Loeb","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2011.06.022_bib0105","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/nm1087","article-title":"Cancer genes and the pathways they control","volume":"10","author":"Vogelstein","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.leukres.2011.06.022_bib0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/MOH.0b013e3283257ac7","article-title":"Advancements in the molecular pathogenesis of myelodysplastic syndrome","volume":"16","author":"Epling-Burnette","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.leukres.2011.06.022_bib0115","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1200\/JCO.2010.31.1175","article-title":"Unraveling the molecular pathophysiology of myelodysplastic syndromes","volume":"29","author":"Bejar","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2011.06.022_bib0120","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1182\/blood-2007-01-068346","article-title":"AML1 mutations induced MDS and MDS\/AML in a mouse BMT model","volume":"111","author":"Watanabe-Okochi","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.022_bib0125","doi-asserted-by":"crossref","first-page":"11657","DOI":"10.1158\/0008-5472.CAN-07-0196","article-title":"BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia","volume":"67","author":"Omidvar","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2011.06.022_bib0130","doi-asserted-by":"crossref","first-page":"18238","DOI":"10.1073\/pnas.0607057103","article-title":"Human cancers express a mutator phenotype","volume":"103","author":"Bielas","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2011.06.022_bib0135","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0140-6736(00)49915-0","article-title":"The distribution of secondary growths in cancer of the breast","volume":"133","author":"Paget","year":"1889","journal-title":"Lancet"},{"key":"10.1016\/j.leukres.2011.06.022_bib0140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/35077241","article-title":"The microenvironment of the tumour\u2013host interface","volume":"411","author":"Liotta","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2011.06.022_bib0145","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrc1477","article-title":"Friends or foes\u2014bipolar effects of the tumour stroma in cancer","volume":"4","author":"Mueller","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.leukres.2011.06.022_bib0150","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.coph.2010.06.010","article-title":"Tumor\u2013stromal cell interactions and opportunities for therapeutic intervention","volume":"10","author":"Udagawa","year":"2010","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.leukres.2011.06.022_bib0155","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.bjc.6601611","article-title":"Tumour-derived TGF-beta1 modulates myofibroblast differentiation and promotes HGF\/SF-dependent invasion of squamous carcinoma cells","volume":"90","author":"Lewis","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.leukres.2011.06.022_bib0160","first-page":"5002","article-title":"Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium","volume":"59","author":"Olumi","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2011.06.022_bib0165","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1242\/jcs.01000","article-title":"The stroma as a crucial target in rat mammary gland carcinogenesis","volume":"117","author":"Maffini","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1016\/j.leukres.2011.06.022_bib0170","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1002\/path.2842","article-title":"Genetic changes in tumour microenvironments","volume":"223","author":"Campbell","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.leukres.2011.06.022_bib0175","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nature08486","article-title":"Pten in stromal fibroblasts suppresses mammary epithelial tumours","volume":"461","author":"Trimboli","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2011.06.022_bib0180","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/nrc1653","article-title":"Neurofibromatosis type 1\u2014a model for nervous system tumour formation?","volume":"5","author":"Rubin","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.leukres.2011.06.022_bib0185","first-page":"8573","article-title":"Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity","volume":"63","author":"Bajenaru","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.leukres.2011.06.022_bib0190","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-2141.2000.02467.x","article-title":"Abnormalities of adherent layers grown from bone marrow of patients with myelodysplasia","volume":"111","author":"Tennant","year":"2000","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2011.06.022_bib0195","first-page":"1038","article-title":"Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes","volume":"86","author":"Tauro","year":"2001","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2011.06.022_bib0200","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0145-2126(01)00193-X","article-title":"In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome","volume":"26","author":"Flores-Figueroa","year":"2002","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.06.022_bib0205","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1073\/pnas.0712391105","article-title":"Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function","volume":"105","author":"Marcondes","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.leukres.2011.06.022_bib0210","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/nature08851","article-title":"Bone progenitor dysfunction induces myelodysplasia and secondary leukaemia","volume":"464","author":"Raaijmakers","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.leukres.2011.06.022_bib0215","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF02983556","article-title":"Immunology of B7-H1 and its roles in human diseases","volume":"78","author":"Tamura","year":"2003","journal-title":"Int J Hematol"},{"key":"10.1016\/j.leukres.2011.06.022_bib0220","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood-2009-12-255125","article-title":"Interferon-gamma and tumor necrosis factor-alpha induce an immunoinhibitory molecule, B7-H1, via nuclear factor-kappaB activation in blasts in myelodysplastic syndromes","volume":"116","author":"Kondo","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.022_bib0225","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0145-2126(95)00044-O","article-title":"Spontaneous cytokine overproduction by peripheral blood mononuclear cells from patients with myelodysplastic syndromes and aplastic anemia","volume":"19","author":"Koike","year":"1995","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.06.022_bib0230","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/sj.leu.2400844","article-title":"Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes","volume":"11","author":"Kitagawa","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.06.022_bib0235","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood.V85.11.3183.bloodjournal85113183","article-title":"Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro","volume":"85","author":"Maciejewski","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.022_bib0240","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2005-05-1989","article-title":"NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome","volume":"107","author":"Braun","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.022_bib0245","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.leukres.2007.03.026","article-title":"Increased apoptosis of circulating T cells in myelodysplastic syndromes","volume":"31","author":"Shioi","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.06.022_bib0250","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1182\/blood-2007-11-123141","article-title":"B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells","volume":"111","author":"Azuma","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.022_bib0255","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1158\/1078-0432.CCR-04-2672","article-title":"Expression of functional B7-H2 and B7.2 costimulatory molecules and their prognostic implications in de novo acute myeloid leukemia","volume":"11","author":"Tamura","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.leukres.2011.06.022_bib0260","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/CJI.0b013e31802e085a","article-title":"The new B7s: playing a pivotal role in tumor immunity","volume":"30","author":"Flies","year":"2007","journal-title":"J Immunother"},{"key":"10.1016\/j.leukres.2011.06.022_bib0265","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-2141.2007.06539.x","article-title":"Regulation of angiogenesis in the bone marrow of myelodysplastic syndromes transforming to overt leukaemia","volume":"137","author":"Keith","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.leukres.2011.06.022_bib0270","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/sj.leu.2405069","article-title":"Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes","volume":"22","author":"Della Porta","year":"2008","journal-title":"Leukemia"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611003079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611003079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T10:58:06Z","timestamp":1712660286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611003079"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0145212611003079"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.06.022","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}